⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL102511 | 0.93 | — | — | |
| SCHEMBL102091 | 0.93 | — | — | |
| SCHEMBL25391815 | 0.93 | — | — | |
| SCHEMBL1538646 | 0.90 | KMT2A (0.35) | — | |
| SCHEMBL1538391 | 0.90 | KMT2A (0.35) | — | |
| SCHEMBL1538419 | 0.90 | KMT2A (0.35) | — | |
| SCHEMBL1089080 | 0.90 | KMT2A (0.35) | — | |
| SCHEMBL2325814 | 0.89 | — | — | |
| SCHEMBL104445 | 0.89 | CA1 (0.33) | — | |
| SCHEMBL231283 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024126648-A1 | SULFOXIMINES AS INHIBITORS OF NaV1.8 | Grünenthal GmbH (DE) | 2024-06-20 | — | — | WO | claimed |
| EP-4385979-A1 | MULTICYCLIC INHIBITORS OF NAV1.8 | Grünenthal GmbH (DE) | 2024-06-19 | — | — | EP | claimed |
| EP-4385980-A1 | INDAZOLES AS INHIBITORS OF NAV1.8 | Grünenthal GmbH (DE) | 2024-06-19 | — | — | EP | claimed |
| EP-4385984-A1 | PYRIDINE-N-OXIDES AS INHIBITORS OF NAV1.8 | Grünenthal GmbH (DE) | 2024-06-19 | — | — | EP | claimed |
| WO-2024083223-A1 | MACROCYCLIC COMPOUNDS AND MEDICAL USE THEREOF | 正大天晴药业集团股份有限公司 | 2024-04-25 | — | — | WO | claimed |
| US-20240041889-A1 | COMBINATION THERAPY WITH ADENOSINE RECEPTOR ANTAGONISTS | TEON THERAPEUTICS INC (US) | 2024-02-08 | — | — | US | claimed |
| EP-4192916-A1 | COMBINATION THERAPY WITH ADENOSINE RECEPTOR ANTAGONISTS | Teon Therapeutics, Inc. (US) | 2023-06-14 | — | — | EP | claimed |
| WO-2023078463-A1 | AZOBENZENE COMPOUND AND APPLICATION THEREOF | 正大天晴药业集团股份有限公司 | 2023-05-11 | — | — | WO | claimed |
| WO-2023039125-A1 | ADENOSINE RECEPTOR AGONISTS FOR USE IN THE TREATMENT OF CANCER | TEON THERAPEUTICS, INC. (US) | 2023-03-16 | — | — | WO | claimed |
| US-20220135557-A1 | RET INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2022-05-05 | — | — | US | claimed |
| EP-0771196-B1 | EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS | LILLY CO ELI (US) | 1999-12-08 | — | — | EP | claimed |
| EP-0866700-A4 | HEMOREGULATORY COMPOUNDS | SMITHKLINE BEECHAM CORP (US) | 1999-04-07 | — | — | EP | claimed |
| EP-0882044-A1 | 1,4-DIHYDROPYRIDINE COMPOUNDS AS BRADYKININ ANTAGONISTS | PFIZER INC. (US) | 1998-12-09 | — | — | EP | claimed |
| EP-0866700-A1 | HEMOREGULATORY COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-09-30 | — | — | EP | claimed |
| EP-0861255-A1 | HEMOREGULATORY COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-09-02 | — | — | EP | claimed |
| WO-1997030048-A1 | 1,4-DIHYDROPYRIDINE COMPOUNDS AS BRADYKININ ANTAGONISTS | PFIZER PHARMACEUTICALS INC. (JP) | 1997-08-21 | — | — | WO | claimed |
| WO-1997017958-A1 | HEMOREGULATORY COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-05-22 | — | — | WO | claimed |
| WO-1997018214-A1 | HEMOREGULATORY COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-05-22 | — | — | WO | claimed |
| US-5294531-A | BicycloUm.n.oealkane-1-ylcarbonylacetamide compound | FUJI PHOTO FILM CO., LTD. (JP) | 1994-03-15 | — | — | US | claimed |
| US-4472383-A | HYPOTENSIVE AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1984-09-18 | — | — | US | claimed |